BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23106271)

  • 21. Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2015 Nov; 19(11):1276-89. PubMed ID: 26467578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 23. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In reply.
    Takiff H; Alame-Emane AK; Pierre-Audigier C; Gicquel B
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):282-3. PubMed ID: 26792487
    [No Abstract]   [Full Text] [Related]  

  • 25. AIDS and tuberculosis - a lethal combination.
    Ojcius D
    Nat Rev Microbiol; 2004 Nov; 2(11):858. PubMed ID: 15523763
    [No Abstract]   [Full Text] [Related]  

  • 26. No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
    Cobelens F; Gebhard A; van den Hof S
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):282. PubMed ID: 26792486
    [No Abstract]   [Full Text] [Related]  

  • 27. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resistant tuberculosis: a molecular review].
    Rossetti ML; Valim AR; Silva MS; Rodrigues VS
    Rev Saude Publica; 2002 Aug; 36(4):525-32. PubMed ID: 12364929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.
    Metcalfe JZ; Vittinghoff E; Hopewell PC
    Clin Infect Dis; 2015 Mar; 60(6):970. PubMed ID: 25527651
    [No Abstract]   [Full Text] [Related]  

  • 30. Tuberculosis susceptibility--implications for drug development and therapy.
    Snell NJ
    Expert Opin Pharmacother; 2003 Sep; 4(9):1455-60. PubMed ID: 12943474
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-resistant tuberculosis transmission and resistance amplification within families.
    Seddon JA; Warren RM; Enarson DA; Beyers N; Schaaf HS
    Emerg Infect Dis; 2012 Aug; 18(8):1342-5. PubMed ID: 22840848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious disease. Approval of novel TB drug celebrated--with restraint.
    Cohen J
    Science; 2013 Jan; 339(6116):130. PubMed ID: 23307714
    [No Abstract]   [Full Text] [Related]  

  • 33. Why is long-term therapy required to cure tuberculosis?
    Connolly LE; Edelstein PH; Ramakrishnan L
    PLoS Med; 2007 Mar; 4(3):e120. PubMed ID: 17388672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-resistant tuberculosis.
    Böttger EC
    Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
    [No Abstract]   [Full Text] [Related]  

  • 35. Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children.
    Morales Pérez C; Gomez-Pastrana D; Aragón Fernández C; Pérez Escolano E
    Arch Bronconeumol (Engl Ed); 2019 Jul; 55(7):388-390. PubMed ID: 30635203
    [No Abstract]   [Full Text] [Related]  

  • 36. [The problem of resistance in the treatment of Mycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy].
    Seydel JK; Schaper KJ
    Pharm Unserer Zeit; 1995 Nov; 24(6):313-23. PubMed ID: 8592712
    [No Abstract]   [Full Text] [Related]  

  • 37. Microscopic observation drug susceptibility (MODS): where are we going?
    Kam KM
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):127. PubMed ID: 24429301
    [No Abstract]   [Full Text] [Related]  

  • 38. Overcoming drug resistance in TB: an update.
    Consalvi S; Poce G; Scarpecci C; Biava M
    Future Microbiol; 2020 Nov; 15():1607-1609. PubMed ID: 33215545
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-resistant tuberculosis: pediatric guidelines.
    Al-Dabbagh M; Lapphra K; McGloin R; Inrig K; Schaaf HS; Marais BJ; Sauve L; Kitai I; Kollmann TR
    Pediatr Infect Dis J; 2011 Jun; 30(6):501-5. PubMed ID: 21297522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.